Canine Athlete Initiative

In this edition of Genome Barks we hear from Dr. Shila Nordone, Chief Scientific Officer of the Canine Health Foundation. Dr. Nordone discusses the Canine Athlete Initiative (CAI), a newly launched fundraising and public awareness campaign of CHF. The Initiative focuses on providing information on the proper conditioning, nutrition, training, and rehabilitation that are specific to the canine athlete. Dr. Nordone also discusses the importance of funding research in the emerging field of canine sports medicine, which benefits not only canine athletes, but all dogs.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Atopic Dermatitis

In this edition of Genome Barks we hear from Dr. Natasha Olby, professor of neurology and Dr. Thierry Olivry, professor of immunedermatology at North Carolina State University College of Veterinary Medicine discuss their CHF-funded research of atopic dermatitis, a chronic allergic skin disease. Drs. Olby and Olivry are researching the gene or genes responsible for this disease, hoping for better treatments, earlier intervention, and possibly a cure.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Urban Search and Rescue Dogs

In this edition of Genome Barks we hear from Dr. Cindy Otto, Associate Professor of Critical Care at the University of Pennsylvania School of Veterinary Medicine and the Director of the Penn Vet Working Dog Center. Dr. Otto discusses her CHF-funded research which has monitored the search and rescue dogs that worked in the 9/11 recovery efforts. Dr. Otto also discusses the Penn Vet Working Dog center, the importance of increasing detection dog breeding in the United States, and how science can be used to identify key characteristics that make for highly successful search and rescue dogs.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Canine Lymphoma Treatment Research

In this edition of Genome Barks we hear from Dr. Nicola Mason, Assistant Professor of Medicine and Pathobiology at the University of Pennsylvania School of Veterinary Medicine. Dr. Mason discusses her research of diffuse large B-cell lymphoma and shares how the strides made in treating dogs with this type of lymphoma are impacting lymphoma treatment in people.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Canine Osteosarcoma Research

In this edition of Genome Barks we hear from Dr. Kerstin Lindblad-Toh, a professor in comparative genomics at Uppsala University and the Scientific Director of Vertebrate Genome Biology at the Broad Institute.

Dr. Lindblad-Toh discusses current research on osteosarcoma, including how identification of the unique genes and associated biological pathways that define osteosarcoma can make a difference in how this disease is diagnosed and treated, not just in dogs, but in humans too.

Please note: This podcast does not have the high quality sound you are accustomed to from AKC Canine Health Foundation podcasts. Dr. Lindblad-Toh was kind enough to record this podcast via an international telephone connection. We apologize for the inconvenience, but because the information in this podcast is very valuable to dog owners, we hope you will find it worthwhile to listen.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Canine Hemangiosarcoma Research

In this special 35 minute edition of Genome Barks we hear from Dr. Jaime Modiano of the University of Minnesota. Dr. Modiano discusses his CHF-funded research of hemangiosarcoma, as well as providing an overview on the progress being made in the field of hemangiosarcoma research.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

The Future of Cancer Research

In this edition of Genome Barks we hear from Dr. Bruce Smith of the Auburn University Research Initiative in Cancer (AURIC). The Auburn College of Veterinary Medicine recently received a $1 million appropriation from the state of Alabama for cancer research. Specifically, Dr. Smith discusses the focus of the "One Medicine" approach which links human, animal, and environmental health, and where discoveries in one species advance the health in all species. For more information on AURIC visit www.auriconline.org.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Pet Cancer Awareness Month

In this special edition of Genome Barks we hear from Dr. Shila Nordone, Chief Scientific Officer of the AKC Canine Health Foundation. May is Pet Cancer Awareness Month and throughout the month CHF will be highlighting currently-funded cancer research projects, providing information about different types of canine cancer, care for dogs with cancer, and other cancer-related health resources. In this podcast, Dr. Nordone provides an overview of the Foundation's commitment to canine cancer research, the future of canine cancer research and prevention, and the One Health / One Medicine approach to research which benefits not only dogs, but humans as well.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Nutrigenomics

In this edition of Genome Barks we hear from Dr. Rondo Middleton of Nestlé Purina PetCare Company. Dr. Middleton discusses nutrigenomics, a field of study that measures how a nutrient or diet affects gene expression. Dr. Middleton shares the progress in the field, how studying nutrigenomics enables researchers to create diets that are healthier for dogs, and how these diets and nutrition plans can address specific symptoms of some canine health concerns.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.

Canine Allergies

In this edition of Genome Barks we hear from Dr. Bruce Hammerberg of North Carolina State University College of Veterinary Medicine. Dr. Hammerberg discusses allergy season, how it impacts dogs, common allergens, and treatments. Dr. Hammerberg also discusses his CHF-funded research that looks to develop a novel therapeutic drug for canine allergies.

This podcast was made possible thanks to the generous support of the Kenneth A. Scott Charitable Trust, a KeyBank Trust.